| 51 |
31897925 | Management of sinonasal adenocarcinomas with anterior skull base extension. | 2020 Dec |
1 |
| 52 |
31898732 | Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer. | 2020 Jan 31 |
1 |
| 53 |
31935430 | GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. | 2020 Apr |
1 |
| 54 |
32044796 | Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61. | 2020 Jul |
1 |
| 55 |
32052927 | LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling. | 2020 Apr |
1 |
| 56 |
32063580 | Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill. | 2020 Apr |
2 |
| 57 |
32088177 | Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory. | 2020 May 5 |
2 |
| 58 |
32122297 | Sirt2-associated transcriptome modifications in cisplatin-induced neuronal injury. | 2020 Mar 2 |
1 |
| 59 |
32135156 | Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells. | 2020 May |
3 |
| 60 |
32152233 | PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice. | 2020 Jun |
1 |
| 61 |
32211658 | Cisplatin binds to the MDM2 RING finger domain and inhibits the ubiquitination activity. | 2020 Apr 28 |
2 |
| 62 |
32217375 | Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance. | 2020 Jun |
3 |
| 63 |
32237195 | Preclinical Anticancer Activity of an Electron-Deficient Organoruthenium(II) Complex. | 2020 Jun 4 |
2 |
| 64 |
32238696 | Pro-apoptotic functions of TRAF2 in p53-mediated apoptosis induced by cisplatin. | 2020 |
3 |
| 65 |
32355541 | Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells. | 2020 |
2 |
| 66 |
32368398 | Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression. | 2020 |
2 |
| 67 |
32382008 | The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53. | 2020 May 7 |
2 |
| 68 |
32466567 | Activation of Mitochondrial 2-Oxoglutarate Dehydrogenase by Cocarboxylase in Human Lung Adenocarcinoma Cells A549 Is p53/p21-Dependent and Impairs Cellular Redox State, Mimicking the Cisplatin Action. | 2020 May 26 |
1 |
| 69 |
32468080 | Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents. | 2020 Jun |
1 |
| 70 |
32489467 | Cytoplasm-localized SIRT1 downregulation attenuates apoptosis and cell cycle arrest in cisplatin-resistant lung cancer A549 cells. | 2020 |
1 |
| 71 |
32512936 | A Co-Delivery System of Curcumin and p53 for Enhancing the Sensitivity of Drug-Resistant Ovarian Cancer Cells to Cisplatin. | 2020 Jun 4 |
1 |
| 72 |
32533982 | Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis. | 2020 Oct |
1 |
| 73 |
32630700 | The Phytochemical Indicaxanthin Synergistically Enhances Cisplatin-Induced Apoptosis in HeLa Cells via Oxidative Stress-Dependent p53/p21waf1 Axis. | 2020 Jul 2 |
1 |
| 74 |
32641008 | Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells. | 2020 Jul 8 |
4 |
| 75 |
32695207 | Ginsenoside Rh1 Alleviates HK-2 Apoptosis by Inhibiting ROS and the JNK/p53 Pathways. | 2020 |
1 |
| 76 |
32731241 | The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. | 2020 |
1 |
| 77 |
32738659 | Effective treatment of drug-resistant lung cancer via a nanogel capable of reactivating cisplatin and enhancing early apoptosis. | 2020 Oct |
1 |
| 78 |
32742376 | TP53 mutation influences the efficacy of treatment of colorectal cancer cell lines with a combination of sirtuin inhibitors and chemotherapeutic agents. | 2020 Aug |
1 |
| 79 |
32818504 | Aconitase 2 sensitizes MCF-7 cells to cisplatin eliciting p53-mediated apoptosis in a ROS-dependent manner. | 2020 Oct |
2 |
| 80 |
32825184 | HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3. | 2020 Aug 19 |
4 |
| 81 |
32867831 | Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway. | 2020 Sep 1 |
5 |
| 82 |
32881246 | Pioglitazone alleviates cisplatin nephrotoxicity by suppressing mitochondria-mediated apoptosis via SIRT1/p53 signalling. | 2020 Oct |
2 |
| 83 |
32947166 | Combined treatment with acetazolamide and cisplatin enhances the chemosensitivity of human head and neck squamous cell carcinoma TU868 cells. | 2020 Nov |
1 |
| 84 |
32974127 | p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer. | 2020 |
1 |
| 85 |
33034274 | Nipped-B-like Protein Sensitizes Esophageal Squamous Cell Carcinoma Cells to Cisplatin via Upregulation of PUMA. | 2020 Jan-Dec |
3 |
| 86 |
33040724 | Regulation of Thiamine (Vitamin B1)-Dependent Metabolism in Mammals by p53. | 2020 Jul |
5 |
| 87 |
33086658 | The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy. | 2020 Oct 19 |
2 |
| 88 |
33163850 | Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs. | 2020 |
1 |
| 89 |
33174043 | Identifying the mechanisms underlying the protective effect of tetramethylpyrazine against cisplatin‑induced in vitro ototoxicity in HEI‑OC1 auditory cells using gene expression profiling. | 2020 Dec |
1 |
| 90 |
33302475 | RNA-Seq Analysis of Cisplatin and the Monofunctional Platinum(II) Complex, Phenanthriplatin, in A549 Non-Small Cell Lung Cancer and IMR90 Lung Fibroblast Cell Lines. | 2020 Dec 8 |
1 |
| 91 |
33396303 | Adaptation to Endoplasmic Reticulum Stress Enhances Resistance of Oral Cancer Cells to Cisplatin by Up-Regulating Polymerase η and Increasing DNA Repair Efficiency. | 2020 Dec 31 |
1 |
| 92 |
33520705 | TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner. | 2020 |
1 |
| 93 |
30144378 | ADP sensitizes ZL55 cells to the activity of cisplatin. | 2019 Apr |
4 |
| 94 |
30445600 | TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome. | 2019 Jun 10 |
1 |
| 95 |
30447351 | N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation. | 2019 Jan |
1 |
| 96 |
30478746 | The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines. | 2019 Feb |
1 |
| 97 |
30538112 | Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer. | 2019 Apr 15 |
1 |
| 98 |
30675226 | MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53. | 2019 Feb |
2 |
| 99 |
30690027 | Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer. | 2019 Mar 1 |
1 |
| 100 |
30723502 | Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells. | 2019 |
2 |